search
Back to results

TAP vs Surgical Infiltration of Local Anesthetic in Laparoscopic and Robotic Hysterectomy

Primary Purpose

Acute Pain

Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Liposomal Bupivacaine
Bupivacaine
Ultrasound
Epinephrine
acetaminophen
ibuprofen
Oxycodone
Sponsored by
University of Minnesota
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Acute Pain

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • ASA physical status I-III
  • Females >/=18-years of age
  • Scheduled for laparoscopic/robot-assisted hysterectomy.

Exclusion Criteria

  • Contraindication to surgical infiltration or regional blockade
  • History of long term opioid intake (greater than 3 weeks prior to surgery) or chronic pain disorder
  • Inability to understand the informed consent and demands of the study
  • Surgery scheduled to start after 1700

Sites / Locations

  • University of Minnesota

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

TAP-Block with liposomal bupivacaine

Surgical infiltration with bupivacaine

Arm Description

TAP infiltration will contain 10 mL of 0.25 % bupivacaine with epinephrine injected followed by 20 mL of a 50:50 mixture of liposomal bupivacaine and normal saline. This will then be repeated on the contralateral side. In the same arm the surgeon infiltration into the incision will consist of 10 ml of normal saline per port site, 5 ml prior to incision and 5 ml prior to closure at each port site.

Surgical Infiltration of the study solution will be performed both prior to incision and at the end of surgery just prior to closure of incisions. At each time, the surgeon will inject 5 mL of 0.25% bupivacaine into each of the port site incisions.

Outcomes

Primary Outcome Measures

Total Opioid Use for Pain Control
total opioid used from time 0 after surgery through 72 hours after surgery was complete.

Secondary Outcome Measures

Maximum Pain Scores as Measured by Numerical Pain Rating Scale (0-10)
the Numerical rating scale goes from 0 (lowest) to 10 (highest). Higher values are a worse outcome. The maximal number for maximal pain scores from 0-72 hours is 30. Thus the range for this outcome is 0 to 30 with 30 being a worse outcome. This is because the 0-72 hour maximal pain scores are additive from the 0-24, 24-48, and 48-72 hours. Each 24 hour subset has a maximal score of 10 and adding all three results in maximal score of 30.
Total Opioid Taken by Patient as Tabulated and Converted to Morphine Equivalents
Quality of Recovery 15 (QoR15) Score
The quality of recovery is a survey given to patients. It is 15 questions. The scale of the QOR 15 Score is 0 to 150. 150 is a better outcome.
Overall Benefit of Analgesia Score (OBAS)
The overall benefit of analgesia score is based off 7 questions given to patients it is scored 0-28. 28 is considered a worse outcome.
Number of Participants With Nausea and Vomiting
Length of Time in Phase 1 and Phase 2 of Recovery
time from start of recovery until patient was deemed ready to discharge from phase 2 recovery. Phase 2 recovery is the phase of the post anesthesia care where patients are readied to be discharge form the post anesthesia care unit. There are guidelines with regards to when patients are able to be discharged and when those points are met by the patient they are deemed ready to discharge.
Number of Patients Admitted Post Operatively
Opioid Used From 24-48 Hours Post Surgery
opioids in mg of morphine equivalents used from 24-48 hours after surgery
Total Opioid Taken by Patient as Tabulated and Converted to Morphine Equivalents
opioid use from time 48-72 hours in mg morphine equivalents
Patient Satisfaction With Pain Management
number of patients who answered yes to if they were satisfied with their pain management
Maximal Pain Score of Patient From Time 0-24 Hours After Surgery
the maximal pain score felt by patient during this time period. This is based on a numerical rating scale of 0-10. 0 is best outcome and 10 is worst outcome.
Maximal Pain Score for Patient From Time 24-48 Hours After Surgery
the maximal pain score felt by patient during this time period. This is based on a numerical rating scale of 0-10. 0 is best outcome and 10 is worst outcome.
Maximal Pain Score Patient Felt From 48-72 Hours After Surgery
the maximal pain score felt by patient during this time period. This is based on a numerical rating scale of 0-10. 0 is best outcome and 10 is worst outcome.

Full Information

First Posted
July 28, 2015
Last Updated
January 14, 2019
Sponsor
University of Minnesota
search

1. Study Identification

Unique Protocol Identification Number
NCT02519023
Brief Title
TAP vs Surgical Infiltration of Local Anesthetic in Laparoscopic and Robotic Hysterectomy
Official Title
Transversus Abdominis Plane (TAP) Infiltration vs. Surgical Infiltration of Local Anesthetic in Laparoscopic and Robotic Assisted Hysterectomy
Study Type
Interventional

2. Study Status

Record Verification Date
January 2019
Overall Recruitment Status
Completed
Study Start Date
July 2016 (undefined)
Primary Completion Date
May 2017 (Actual)
Study Completion Date
June 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Minnesota

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Laparoscopic and Robotic assisted hysterectomy is a surgical procedure that is a minimally invasive way in which to remove the uterus, which has less scarring and fewer complications. However, this procedure, much like its open-surgical counterpart, is often associated with significant post-operative pain. To augment this pain there are many different analgesic techniques available to offset pain. Ultrasound-guided transversus abdominis plane (TAP) block is one such procedure involving the injection of a local anesthetic into the plane of the transversus abdominal muscle where the terminal branches of nerves lie. A similar, yet different analgesic approach is that of direct injection of local anesthetic into the incision by the surgeon during or just after surgical procedures. These two approaches have both been proven to decrease post-operative pain in patients for many procedures, but never compared to one another.
Detailed Description
This is a double blinded randomized study. All patients will receive one form of local anesthetic pain relief either from TAP or infiltration. Patients will be randomized to one of two study arms in a double-blinded, placebo controlled study. All patients will receive a TAP infiltration and all patients will receive infiltration into the incision. In one arm the TAP infiltration will contain 10 mL of 0.25 % bupivacaine with epinephrine injected followed by 20 mL of a 50:50 mixture of liposomal bupivacaine and normal saline. This will then be repeated on the contralateral side. In the same arm the surgeon infiltration into the incision will consist of 10 ml of normal saline per port site, 5 ml prior to incision and 5 ml prior to closure at each port site. In the second arm the bilateral TAP infiltration will consist of 30 mL of normal saline per side. In the same arm the surgeon infiltration will consist of 10 mL of 0.25% bupivacaine per port site. The surgeon infiltration will consist of 5 ml of 0.25% bupivacaine prior to incision and 5 ml of 0.25% bupivacaine prior to closure at each port site. A TAP infiltration is an injection of local anesthetic under the covering of the transversus abdominis muscle layer which provides effective post operative analgesia.2-5 This layer is found using an ultrasound, which is a beam of high frequency sound that allows one to visualize images in the body. Then using this ultrasound the investigators can see our needle as it pierces the covering of the transversus abdominis muscle layer and watch as the local anesthetic is infiltrated into this plane. This is done on both sides of the abdomen to provide analgesia to the skin, muscle, and facial layers of the abdomen. This is currently standard of care at our institution and will be performed within one hour of surgical incision. The injection will consist of 10 mL of 0.25% bupivacaine with epinephrine followed by 20 mL of liposomal bupivacaine saline mixture or 10 ml of saline followed by 20 ml of saline and then repeated on the contralateral side. Surgical Infiltration of the study solution will be performed both prior to incision and at the end of surgery just prior to closure of incisions. At each time, the surgeon will inject 5 mL of 0.25% bupivacaine into each of the port site incisions. Investigational Drug Service (IDS) pharmacy will be charged with the blinding of medications vs. saline for these procedures. Following the procedure, all individuals will receive scheduled acetaminophen (1 gram every 6 hours), scheduled ibuprofen (800 mg every 8 hours), and PRN oxycodone 5-10mg q4h if pain is rated at more than 5 out of 10 on a numerical pain scale.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
87 (Actual)

8. Arms, Groups, and Interventions

Arm Title
TAP-Block with liposomal bupivacaine
Arm Type
Experimental
Arm Description
TAP infiltration will contain 10 mL of 0.25 % bupivacaine with epinephrine injected followed by 20 mL of a 50:50 mixture of liposomal bupivacaine and normal saline. This will then be repeated on the contralateral side. In the same arm the surgeon infiltration into the incision will consist of 10 ml of normal saline per port site, 5 ml prior to incision and 5 ml prior to closure at each port site.
Arm Title
Surgical infiltration with bupivacaine
Arm Type
Active Comparator
Arm Description
Surgical Infiltration of the study solution will be performed both prior to incision and at the end of surgery just prior to closure of incisions. At each time, the surgeon will inject 5 mL of 0.25% bupivacaine into each of the port site incisions.
Intervention Type
Drug
Intervention Name(s)
Liposomal Bupivacaine
Other Intervention Name(s)
Exparel
Intervention Description
In one arm the TAP infiltration will contain 10 mL of 0.25 % bupivacaine with epinephrine injected followed by 20 mL of a 50:50 mixture of liposomal bupivacaine and normal saline. This will then be repeated on the contralateral side.
Intervention Type
Drug
Intervention Name(s)
Bupivacaine
Intervention Description
Surgical Infiltration of the study solution will be performed both prior to incision and at the end of surgery just prior to closure of incisions. At each time, the surgeon will inject 5 mL of 0.25% bupivacaine into each of the port site incisions.
Intervention Type
Device
Intervention Name(s)
Ultrasound
Intervention Description
An ultrasound, which is a beam of high frequency sound that allows one to visualize images in the body, will be used to aid investigators to observe the local anesthetic being infiltrated into the plane
Intervention Type
Drug
Intervention Name(s)
Epinephrine
Intervention Description
TAP infiltration will contain 10 mL of 0.25 % bupivacaine with epinephrine.
Intervention Type
Drug
Intervention Name(s)
acetaminophen
Intervention Description
all individuals will receive scheduled acetaminophen (1 gram every 6 hours),
Intervention Type
Drug
Intervention Name(s)
ibuprofen
Intervention Description
all individuals will receive scheduled ibuprofen (800 mg every 8 hours)
Intervention Type
Drug
Intervention Name(s)
Oxycodone
Intervention Description
all individuals will receive PRN oxycodone 5-10mg q4h if pain is rated at more than 5 out of 10 on a numerical pain scale.
Primary Outcome Measure Information:
Title
Total Opioid Use for Pain Control
Description
total opioid used from time 0 after surgery through 72 hours after surgery was complete.
Time Frame
72 hours
Secondary Outcome Measure Information:
Title
Maximum Pain Scores as Measured by Numerical Pain Rating Scale (0-10)
Description
the Numerical rating scale goes from 0 (lowest) to 10 (highest). Higher values are a worse outcome. The maximal number for maximal pain scores from 0-72 hours is 30. Thus the range for this outcome is 0 to 30 with 30 being a worse outcome. This is because the 0-72 hour maximal pain scores are additive from the 0-24, 24-48, and 48-72 hours. Each 24 hour subset has a maximal score of 10 and adding all three results in maximal score of 30.
Time Frame
0-72 hours post-procedure
Title
Total Opioid Taken by Patient as Tabulated and Converted to Morphine Equivalents
Time Frame
0-24 post-procedure
Title
Quality of Recovery 15 (QoR15) Score
Description
The quality of recovery is a survey given to patients. It is 15 questions. The scale of the QOR 15 Score is 0 to 150. 150 is a better outcome.
Time Frame
72 hours post-procedure
Title
Overall Benefit of Analgesia Score (OBAS)
Description
The overall benefit of analgesia score is based off 7 questions given to patients it is scored 0-28. 28 is considered a worse outcome.
Time Frame
72 hours post-procedure
Title
Number of Participants With Nausea and Vomiting
Time Frame
72 hours post-procedure
Title
Length of Time in Phase 1 and Phase 2 of Recovery
Description
time from start of recovery until patient was deemed ready to discharge from phase 2 recovery. Phase 2 recovery is the phase of the post anesthesia care where patients are readied to be discharge form the post anesthesia care unit. There are guidelines with regards to when patients are able to be discharged and when those points are met by the patient they are deemed ready to discharge.
Time Frame
an expected average of 120 mins
Title
Number of Patients Admitted Post Operatively
Time Frame
72 hours post-procedure
Title
Opioid Used From 24-48 Hours Post Surgery
Description
opioids in mg of morphine equivalents used from 24-48 hours after surgery
Time Frame
24-48 hours after the end of surgery
Title
Total Opioid Taken by Patient as Tabulated and Converted to Morphine Equivalents
Description
opioid use from time 48-72 hours in mg morphine equivalents
Time Frame
48-72 hours after end of surgery
Title
Patient Satisfaction With Pain Management
Description
number of patients who answered yes to if they were satisfied with their pain management
Time Frame
at 72 hours after surgery
Title
Maximal Pain Score of Patient From Time 0-24 Hours After Surgery
Description
the maximal pain score felt by patient during this time period. This is based on a numerical rating scale of 0-10. 0 is best outcome and 10 is worst outcome.
Time Frame
0-24 hours after surgery
Title
Maximal Pain Score for Patient From Time 24-48 Hours After Surgery
Description
the maximal pain score felt by patient during this time period. This is based on a numerical rating scale of 0-10. 0 is best outcome and 10 is worst outcome.
Time Frame
24-48 hours after surgery
Title
Maximal Pain Score Patient Felt From 48-72 Hours After Surgery
Description
the maximal pain score felt by patient during this time period. This is based on a numerical rating scale of 0-10. 0 is best outcome and 10 is worst outcome.
Time Frame
48-72 hours after surgery

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ASA physical status I-III Females >/=18-years of age Scheduled for laparoscopic/robot-assisted hysterectomy. Exclusion Criteria Contraindication to surgical infiltration or regional blockade History of long term opioid intake (greater than 3 weeks prior to surgery) or chronic pain disorder Inability to understand the informed consent and demands of the study Surgery scheduled to start after 1700
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Melissa Geller, MD
Organizational Affiliation
University of Minnesota
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Minnesota
City
Minneapolis
State/Province
Minnesota
ZIP/Postal Code
55455
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
25170277
Citation
Feierman DE, Kronenfeld M, Gupta PM, Younger N, Logvinskiy E. Liposomal bupivacaine infiltration into the transversus abdominis plane for postsurgical analgesia in open abdominal umbilical hernia repair: results from a cohort of 13 patients. J Pain Res. 2014 Aug 16;7:477-82. doi: 10.2147/JPR.S65151. eCollection 2014.
Results Reference
background
PubMed Identifier
22381092
Citation
Mitchell AU, Torup H, Hansen EG, Petersen PL, Mathiesen O, Dahl JB, Rosenberg J, Moller AM. Effective dermatomal blockade after subcostal transversus abdominis plane block. Dan Med J. 2012 Mar;59(3):A4404.
Results Reference
background
PubMed Identifier
19561014
Citation
Niraj G, Searle A, Mathews M, Misra V, Baban M, Kiani S, Wong M. Analgesic efficacy of ultrasound-guided transversus abdominis plane block in patients undergoing open appendicectomy. Br J Anaesth. 2009 Oct;103(4):601-5. doi: 10.1093/bja/aep175. Epub 2009 Jun 26.
Results Reference
background
PubMed Identifier
20175754
Citation
Petersen PL, Mathiesen O, Torup H, Dahl JB. The transversus abdominis plane block: a valuable option for postoperative analgesia? A topical review. Acta Anaesthesiol Scand. 2010 May;54(5):529-35. doi: 10.1111/j.1399-6576.2010.02215.x. Epub 2010 Feb 17.
Results Reference
background
PubMed Identifier
21663815
Citation
Singh M, Chin KJ, Chan V. Ultrasound-guided transversus abdominis plane (TAP) block: a useful adjunct in the management of postoperative respiratory failure. J Clin Anesth. 2011 Jun;23(4):303-6. doi: 10.1016/j.jclinane.2010.05.012.
Results Reference
background

Learn more about this trial

TAP vs Surgical Infiltration of Local Anesthetic in Laparoscopic and Robotic Hysterectomy

We'll reach out to this number within 24 hrs